ASMBS Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery

Surgery for Obesity and Related Diseases

Volumn 13, Issue 3, 2017, Pages 371-378

  Eisenberg, Dan ^a,b   Azagury, Dan E ^a   Ghiassi, Saber ^c,d   Grover, Brandon T ^e   Kim, Julie J ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIDGEPORT HOSPITAL   (United States)

^e Gundersen Health System   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; DIAZOXIDE; GLP 1 RECEPTOR ANTAGONIST; GLUCAGON RECEPTOR ANTAGONIST; NIFEDIPINE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

BARIATRIC SURGERY; CLINICAL FEATURE; DIET SUPPLEMENTATION; GASTRIC BYPASS SURGERY; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; MEDICAL SOCIETY; PANCREAS RESECTION; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; POSTPRANDIAL HYPERINSULINEMIC HYPOGLYCEMIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ROUX EN Y GASTRIC BYPASS REVERSAL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH OBSTRUCTION; STOMACH TUBE; SYSTEMATIC REVIEW; GASTROSTOMY; HYPERINSULINISM; MORBID OBESITY; PANCREATECTOMY; POSTOPERATIVE COMPLICATION; POSTPRANDIAL STATE; PROCEDURES; REOPERATION;

BARIATRIC SURGERY; GASTROSTOMY; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; OBESITY, MORBID; PANCREATECTOMY; POSTOPERATIVE COMPLICATIONS; POSTPRANDIAL PERIOD; REOPERATION;

EID: 85009743245     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.12.005     Document Type: Review

References (69)

1. [1] Lim, S.S., Vos, T., Flaxman, A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:9859 (2012), 2224–2260.
2. [2] World Health Organization. Obesity and Overweight Fact Sheet, updated June 2016 [cited 2016 Dec 6]. Available from: www.who.int/mediacentre/factsheets/fs311.
3. [3] Ogden, C.L., Carroll, M.D., Fryar, C.D., Flegal, K.M., Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief 219 (2015), 1–8.
4. [4] Courcoulas, A.P., Christian, N.J., Belle, S.H., et al. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310:22 (2013), 2416–2425.
5. [5] Sjöström, L., Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 273:3 (2013), 219–234.
6. [6] Chang, S.H., Stoll, C.R., Song, J., Varela, J.E., Eagon, C.J., Colditz, G.A., The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 149:3 (2014), 275–287.
7. [7] Service, G.J., Thompson, G.B., Service, F.J., Andrews, J.C., Collazo-Clavell, M.L., Lloyd, R.V., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:3 (2005), 249–254.
8. [8] Patti, M.E., McMahon, G., Mun, E.C., et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:11 (2005), 2236–2240.
9. [9] Coudhary, P., Teh, M.M., Amiel, S.A., Methods of assessment of counterregulation to hypoglycaemia. Roden, M., (eds.) Clinical diabetes research: methods and techniques, 2007, John Wiley & Sons, Ltd., Hoboken, NJ, 77–103.
10. [10] Meier, J.J., Butler, A.E., Galasso, R., Butler, P.C., Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 29:7 (2006), 1554–1559.
11. [11] Pories, W.J., Swanson, M.S., MacDonald, K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:3 (1995), 339–350.
12. [12] Goldfine, A.B., Mun, E.C., Devine, E., et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92:12 (2007), 4678–4685.
13. [13] Buchwald, H., Oien, D.M., Metabolic/bariatric surgery worldwide 2011. Obes Surg., 23(4), 2013, 427–436.
14. [14] Shantavasinkul, P.C., Torquati, A., Corsino, L., Post-gastric bypass hypoglycaemia: a review. Clin Endocrinol 85:1 (2016), 3–9.
15. [15] Lee, C.J., Clark, J.M., Schweitzer, M., et al. Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy. Obesity (Silver Spring) 23:5 (2015), 1079–1084.
16. [16] Abrahamsson, N., Edén Engström, B., Sundbom, M., Karlsson, F.A., Hypoglycemia in everyday life after gastric bypass and duodenal switch. Eur J Endocrinol 173:1 (2015), 91–100.
17. rd, Pender, J.R., et al. Hypoglycemia after Roux-en-Y gastric bypass: the BOLD experience. Obes Surg 24:7 (2014), 1120–1124.
18. [18] Rariy, C.M., Rometo, D., Korytkowski, M., Post-gastric bypass hypoglycemia. Curr Diab Rep, 16(2), 2016, 19.
19. [19] Marsk, R., Jonas, E., Rasmussen, F., Näslund, E., Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 53:11 (2010), 2307–2311.
20. [20] Kellogg, T.A., Bantle, J.P., Leslie, D.B., et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis 4:4 (2008), 492–499.
21. [21] Halperin, F., Patti, M.E., Skow, M., Bajwa, M., Goldfine, A.B., Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes, 2011, 2011, 869536.
22. [22] Emous, M., Ubels, F.L., van Beek, A.P., Diagnostic tools for post-gastric bypass hypoglycaemia. Obes Rev 16:10 (2015), 843–856.
23. [23] Tack, J., Arts, J., Caenepeel, P., De Wulf, D., Bisschops, R., Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 6:10 (2009), 583–590.
24. [24] Malik, S., Mitchell, J.E., Steffen, K., et al. Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery. Obes Res Clin Pract 10:1 (2016), 1–14.
25. [25] Bantle, J.P., Ikramuddin, S., Kellogg, T.A., Buchwald, H., Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg 17:5 (2007), 592–594.
26. [26] Salehi, M., Prigeon, R.L., D'Alessio, D.A., Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 60:9 (2011), 2308–2314.
27. [27] Valderas, J.P., Ahuad, J., Rubio, L., Escalona, M., Pollak, F., Maiz, A., Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels. Obes Surg 22:4 (2012), 582–586.
28. [28] Boettcher, C., Dost, A., Wudy, S.A., et al., German/Austrian Diabetes Prospective Documentation Initiative. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther 17:4 (2015), 275–282.
29. [29] Halverson, J.D., Kramer, J., Cave, A., Permutt, A., Santiago, J., Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery 92:2 (1982), 235–240.
30. [30] Roslin, M., Damani, T., Oren, J., Andrews, R., Yatco, E., Shah, P., Abnormal glucose tolerance testing following gastric bypass demonstrates reactive hypoglycemia. Surg Endosc 25:6 (2011), 1926–1932.
31. [31] Kim, S.H., Liu, T.C., Abbasi, F., et al. Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg 19:11 (2009), 1550–1556.
32. [32] Rabiee, A., Magruder, J.T., Salas-Carrillo, R., et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 167:2 (2011), 199–205.
33. [33] Ritz, P., Vaurs, C., Bertrand, M., Anduze, Y., Guillaume, E., Hanaire, H., Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring. Diabetes Technol Ther 14:8 (2012), 736–740.
34. [34] Cui, Y., Elahi, D., Andersen, D.K., Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 15:10 (2011), 1879–1888.
35. [35] Patti, M.E., Goldfine, A.B., Hypoglycemia after gastric bypass: the dark side of GLP-1. Gastroenterology 146:3 (2014), 605–608.
36. [36] Laferrère, B., Teixeira, J., McGinty, J., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93:7 (2008), 2479–2485.
37. [37] Fischer, L.E., Belt-Davis, D., Khoraki, J., Campos, G., Post-gastric bypass hypoglycemia: diagnosis and management. Herron, D.M., (eds.) Bariatric surgery complications and emergencies, 2016, Springer International Publishing, New York, NY, 253–268.
38. [38] Carpenter, T., Trautmann, M.E., Baron, A.D., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:20 (2005), 2192–2194.
39. [39] Patti, M.E., Li, P., Goldfine, A.B., Insulin response to oral stimuli and glucose effectiveness increased in neuroglycopenia following gastric bypass. Obesity (Silver Spring) 23:4 (2015), 798–807.
40. [40] Jørgensen, N.B., Dirksen, C., Bojsen-Møller, K.N., et al. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 62:9 (2013), 3044–3052.
41. [41] Toft-Nielsen, M., Madsbad, S., Holst, J.J., Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 41:10 (1998), 1180–1186.
42. [42] Salehi, M., Gastaldelli, A., D'Alessio, D.A., Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab 99:6 (2014), 2008–2017.
43. [43] Salehi, M., Gastaldelli, A., D'Alessio, D.A., Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology 146:3 (2014), 669–680.
44. [44] Abrahamsson, N., Engström, B.E., Sundbom, M., Karlsson, F.A., GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication?. Eur J Endocrinol 169:6 (2013), 885–889.
45. [45] Kamvissi, V., Salerno, A., Bornstein, S.R., Mingrone, G., Rubino, F., Incretins or anti-incretins? A new model for the “entero-pancreatic axis”. Horm Metab Res 47:1 (2015), 84–87.
46. [46] Mala, T., Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg Obes Relat Dis 10:6 (2014), 1220–1225.
47. [47] Mathavan, V.K., Arregui, M., Davis, C., Singh, K., Patel, A., Meacham, J., Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc 24:10 (2010), 2547–2555.
48. [48] Carter, C.O., Fernandez, A.Z., McNatt, S.S., Powell, M.S., Conversion from gastric bypass to sleeve gastrectomy for complications of gastric bypass. Surg Obes Relat Dis 12:3 (2016), 572–576.
49. [49] Campos, G.M., Ziemelis, M., Paparodis, R., Ahmed, M., Davis, D.B., Laparoscopic reversal of Roux-en-Y gastric bypass: technique and utility for treatment of endocrine complications. Surg Obes Relat Dis 10:1 (2014), 36–43.
50. [50] Botros, N., Rijnaarts, I., Brandts, H., Bleumink, G., Janssen, I., de Boer, H., Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg 24:11 (2014), 1850–1855.
51. [51] Guseva, N., Phillips, D., Mordes, J.P., Successful treatment of persistent hyperinsulinemic hypoglycemia with nifedipine in an adult patient. Endocr Pract 16:1 (2010), 107–111.
52. [52] Frankhouser, S.Y., Ahmad, A.N., Perilli, G.A., Quintana, B.J., Vengrove, M.A., Post-gastric-bypass hypoglycemia successfully treated with alpha-glucosidase inhibitor therapy. Endocr Pract 19:3 (2013), 511–514.
53. [53] Valderas, J.P., Irribarra, V., Rubio, L., et al. Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects. Obes Surg 21:7 (2011), 902–909.
54. [54] Spanakis, E., Gragnoli, C., Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 19:9 (2009), 1333–1334.
55. [55] Halperin, F., Patti, M.E., Goldfine, A.B., Glucagon treatment for post-gastric bypass hypoglycemia. Obesity (Silver Spring) 18:9 (2010), 1858–1860.
56. [56] Hasegawa, T., Yoneda, M., Nakamura, K., et al. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol 13:12 (1998), 1201–1206.
57. [57] McLaughlin, T., Peck, M., Holst, J., Deacon, C., Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 95:4 (2010), 1851–1855.
58. [58] Z'graggen, K., Guweidhi, A., Steffen, R., et al. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 18:8 (2008), 981–988.
59. [59] Leitman, I.M., Virk, C.S., Avgerinos, D.V., et al. Early results of trans-oral endoscopic plication and revision of the gastric pouch and stoma following Roux-en-Y gastric bypass surgery. JSLS 14:2 (2010), 217–220.
60. [60] Fernández-Esparrach, G., Lautz, D.B., Thompson, C.C., Peroral endoscopic anastomotic reduction improves intractable dumping syndrome in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 6:1 (2010), 36–40.
61. [61] Vilallonga, R., van de Vrande, S., Himpens, J., Laparoscopic reversal of Roux-en-Y gastric bypass into normal anatomy with or without sleeve gastrectomy. Surg Endosc 27:12 (2013), 4640–4648.
62. [62] Clancy, T.E., Moore, F.D. Jr., Zinner, M.J., Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg 10:8 (2006), 1116–1119.
63. [63] Lee, C.J., Brown, T., Magnuson, T.H., Egan, J.M., Carlson, O., Elahi, D., Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia. J Clin Endocrinol Metab 98:7 (2013), E1208–E1212.
64. [64] Alvarez, G.C., Faria, E.N., Beck, M., Girardon, D.T., Machado, A.C., Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obes Surg 17:4 (2007), 550–552.
65. [65] Ünal, B., Uzun, Ö.C., Başsorgun, C.İ., Erdoğan, O., Elpek, G.Ö., A rare complication of gastric bypass (weight loss) surgery: nesidioblastosis. Int J Surg Pathol 23:1 (2015), 68–70.
66. [66] Rumilla, K.M., Erickson, L.A., Service, F.J., et al. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol 22:2 (2009), 239–245.
67. [67] Lash, R.W., Giordano, T.J., Moraitis, A.G., Hodish, I., Histological insights into the pathogenesis of post-Roux-en-Y hyperinsulinaemic hypoglycaemia. Diabetic Med 31:12 (2014), e29–e32.
68. [68] Meier, J.J., Nauck, M.A., Butler, P.C., Comment to: Patti ME, McMahon G, Mun EC, et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240. Diabetologia 49:3 (2006), 607–608 author reply 609–10.
69. [69] Vanderveen, K.A., Grant, C.S., Thompson, G.B., et al. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery 148:6 (2010), 1237–1245.